Skip to content

LEXARIA BIOSCIENCE CORP.: 10-Q filed 2012-09-12

What LEXARIA BIOSCIENCE CORP. reported in its quarterly report filed 2012-09-12 (fiscal Q3 2012): 28 published measures, 84 facts as tagged in accession 0001062993-12-003554.

This filing

Form
10-Q (quarterly report)
Filed
2012-09-12
Fiscal period
fiscal Q3 2012
Accession
0001062993-12-003554 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LEXARIA BIOSCIENCE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-07-314,224,244USD
At 2011-10-314,339,369USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-07-311,836,225USD
At 2011-10-311,678,021USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-07-312,388,019USD
At 2011-10-312,661,348USD
At 2010-10-312,153,653USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-07-3116,445USD
At 2011-10-3131,201USD
At 2011-07-31494,442USD
At 2010-10-3162,989USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-11-01 to 2012-07-31-67,664USD274
2010-11-01 to 2011-07-31-183,021USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-11-01 to 2012-07-31300,000USD274
2010-11-01 to 2011-07-31895,638USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-11-01 to 2012-07-31-247,092USD274
2010-11-01 to 2011-07-31-281,164USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-07-31-4,745,536USD
At 2011-10-31-4,462,618USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-05-01 to 2012-07-3116,431,452shares92
2011-11-01 to 2012-07-3116,431,452shares274
2011-05-01 to 2011-07-3114,276,776shares92
2010-11-01 to 2011-07-3113,451,758shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-05-01 to 2012-07-3116,437,269shares92
2011-11-01 to 2012-07-3116,431,452shares274
2011-05-01 to 2011-07-3114,276,776shares92
2010-11-01 to 2011-07-3113,451,758shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-05-01 to 2012-07-310USD/shares92
2011-11-01 to 2012-07-31-0.02USD/shares274
2011-05-01 to 2011-07-31-0.02USD/shares92
2010-11-01 to 2011-07-31-0.04USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-05-01 to 2012-07-310USD/shares92
2011-11-01 to 2012-07-31-0.02USD/shares274
2011-05-01 to 2011-07-31-0.02USD/shares92
2010-11-01 to 2011-07-31-0.04USD/shares273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-05-01 to 2012-07-310USD92
2011-11-01 to 2012-07-319,589USD274
2011-05-01 to 2011-07-31179,789USD92
2010-11-01 to 2011-07-31179,789USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-07-31517,260USD
At 2011-10-31264,228USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-05-01 to 2012-07-3158,806USD92
2011-11-01 to 2012-07-31171,801USD274
2011-05-01 to 2011-07-3157,554USD92
2010-11-01 to 2011-07-31172,262USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-07-311,836,225USD
At 2011-10-311,078,583USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-07-31497,866USD
At 2011-10-31230,880USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-05-01 to 2012-07-31197,012USD92
2011-11-01 to 2012-07-31653,945USD274
2011-05-01 to 2011-07-31427,325USD92
2010-11-01 to 2011-07-31840,116USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-05-01 to 2012-07-31265,134USD92
2011-11-01 to 2012-07-31371,027USD274
2011-05-01 to 2011-07-31174,356USD92
2010-11-01 to 2011-07-31301,201USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-05-01 to 2012-07-31229,349USD92
2011-11-01 to 2012-07-31517,699USD274
2011-05-01 to 2011-07-31153,329USD92
2010-11-01 to 2011-07-31575,758USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-07-3116,431,452shares
At 2011-10-3116,431,452shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-07-317,117,124USD
At 2011-10-317,107,535USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-07-312,949USD
At 2011-10-312,147USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-05-01 to 2012-07-3168,122USD92
2011-11-01 to 2012-07-31-282,918USD274
2010-11-01 to 2011-10-31-538,226USD365
2011-05-01 to 2011-07-31-252,969USD92
2010-11-01 to 2011-07-31-538,915USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-05-01 to 2012-07-31628USD92
2011-11-01 to 2012-07-312,279USD274
2011-05-01 to 2011-07-312,266USD92
2010-11-01 to 2011-07-314,279USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-05-01 to 2012-07-310USD92
2011-11-01 to 2012-07-310USD274
2011-05-01 to 2011-07-310USD92
2010-11-01 to 2011-07-31425USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-11-01 to 2012-07-31266,986USD274
2010-11-01 to 2011-07-31156,727USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-11-01 to 2012-07-31-140,304USD274
2010-11-01 to 2011-07-31-45,118USD273

Inspect the source

Entity
LEXARIA BIOSCIENCE CORP. / CIK 0001348362
Captured
2026-09-20T07:55:03.045Z
SEC response SHA-256
c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))